The 20 Best Homozygous Familial Hypercholesterolemia (HoFH) Doctors Near Me in Nagano, JP
Find the Top Homozygous Familial Hypercholesterolemia (HoFH) Experts and Specialists
Yushi Oyama practices practicing medicine in Ina, Japan. Oyama is rated as an Experienced expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). They are also highly rated in 1 other condition, according to our data. Their clinical expertise encompasses Xanthoma, Peripheral Artery Disease, Cerebrotendinous Xanthomatosis, Thrombectomy, and Stent Placement.
Takuya Miyagi practices practicing medicine in Ina, Japan. Mr. Miyagi is rated as an Experienced expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Liver Cancer, and Xanthoma.
Kyuhachi Otagiri practices practicing medicine in Ina, Japan. Otagiri is rated as an Experienced expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). They are also highly rated in 2 other conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Xanthoma, Stable Angina, Percutaneous Coronary Intervention (PCI), and Heart Transplant.
Hiroshi Kitabayashi practices practicing medicine in Ina, Japan. Mr. Kitabayashi is rated as an Experienced expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Xanthoma, Coronary Heart Disease, Cerebrotendinous Xanthomatosis, and Thoracic Outlet Syndrome.
Takahiro Sakai practices practicing medicine in Ina, Japan. Mr. Sakai is rated as an Experienced expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Xanthoma, Uterine Fibroids, Coronary Heart Disease, Peripheral Artery Disease, and Percutaneous Coronary Intervention (PCI).
Last Updated: 04/28/2026